Building quality of life assessment into cancer treatment studies
Contenu en anglais
Synthèse
Quality of life is increasingly recognized as an important outcome of cancer treatment. However, quality of life research poses considerable problems in design and implementation. This article provides guidelines for the preparation of phase III therapeutic protocols that include quality of life assessment. The guidelines emphasize the distinct requirements of quality of life research and provide specific recommendations for the questions that need to be addressed in protocol development.
Prognia résume cette recommandation à des fins de consultation et d’enseignement. Il ne s’agit pas d’un avis médical. Vérifiez toujours la recommandation officielle et les protocoles locaux en vigueur avant de l’appliquer.
Supports pédagogiques
En bref
- Date de publication
- 1992
- Région
- United States
- Langue
- English
- Ajout sur Prognia
- 25 juillet 2026
Autres recommandations en oncologie
- SEMERGEN Position Statement on the management of the Oncologic Patient: Comprehensive Approach to Cardiotoxicity in Primary CareSEMERGEN · 2026
- Updated clinical practice guidelines for the management of adult diffuse gliomasEuropean Respiratory Society · 2026
- International guidelines for the delineation of the postoperative clinical target volumes (CTV) for parotid and submandibular gland cancers
